Related Experiment Video

Updated: May 24, 2026

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
19:02

High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors

Published on: March 22, 2011

Retroviral replicating vectors in cancer

Christopher R Logg1, Joan M Robbins, Douglas J Jolly

  • 1Department of Medicine, University of California, Los Angeles, California, USA.

Methods in Enzymology
|February 28, 2012
PubMed

Insights

Replication-competent viruses, specifically retroviral replicating vectors (RRVs), offer a promising approach for cancer treatment. These vectors enable efficient, tumor-selective gene transfer and amplification, leading to durable therapeutic effects.

Area of Science:

  • Oncolytic virology
  • Gene therapy
  • Cancer research

Background:

  • Replication-competent viruses are emerging as a promising cancer treatment modality.
  • Retroviral replicating vectors (RRVs) offer unique advantages for oncolytic virotherapy.

Purpose of the Study:

  • To describe methods for producing and quantifying RRVs.
  • To detail adaptive evolution strategies for generating novel RRV variants.
  • To outline in vitro and in vivo assessments of RRV therapeutic efficacy.

Main Methods:

  • Production and quantitation of retroviral replicating vectors (RRVs).
  • Adaptive evolution and natural selection for RRV variant development.
  • In vitro and in vivo evaluation of RRV efficacy, including prodrug activator gene delivery.

Main Results:

  • RRVs facilitate efficient, non-lytic, tumor-selective gene transfer through exponential amplification.
  • Replication competence allows for generating improved RRV variants via natural selection.
  • Stable integration into cancer cell genomes contributes to long-lasting therapeutic effects.

Conclusions:

  • Retroviral replicating vectors (RRVs) demonstrate significant promise as cancer therapeutics.
  • RRVs possess inherent tumor-specificity due to cell division requirements and immune evasion.
  • Experimental methods are established for RRV development and therapeutic efficacy assessment.

More Related Videos

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells09:40

Production of Replication-Defective Retrovirus by Transient Transfection of 293T cells

Published on: December 4, 2007

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...